Senseonics (NYSE:SENS) announced today that it began the launch of its Eversense 365 sensor with the Sequel Med Tech twiist ...
Stocktwits on MSN
SENS shares surge after first commercial patients use AID-integrated continuous glucose monitor system
Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.
The commercial launch of the integrated products provides people with type 1 diabetes a new level of flexibility and personalization in their diabetes management. Pairing twiist™ with Senseonics’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback